An efficient synthesis of (S)-3-aminomethyl-5-methylhexanoic acid (Pregabalin) via quinine-mediated desymmetrization of cyclic anhydride<\/title><secondary-title>Tetrahedron: Asymmetry<\/secondary-title><\/titles><dates><year>2007<\/year><\/dates><electronic-resource-num>10.1016\/j.tetasy.2007.06.014<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>2<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Kaye AD<\/author><author>Armistead G<\/author><author>Amedio LS et al.<\/author><\/authors><\/contributors><titles><title>Evolving Treatment Strategies for Neuropathic Pain: A Narrative Review.<\/title><secondary-title>Medicina (Kaunas, Lithuania)<\/secondary-title><\/titles><dates><year>2025<\/year><\/dates><electronic-resource-num>10.3390\/medicina61061063<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.mdpi.com\/1648-9144\/61\/6\/1063\/pdf?version=1749542630<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>3<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Mark J. Burk<\/author><author>Pieter D. de Koning<\/author><author>Todd M. Grote et al.<\/author><\/authors><\/contributors><titles><title>An Enantioselective Synthesis of (<i>S<\/i>)-(+)-3-Aminomethyl-5-methylhexanoic Acid via Asymmetric Hydrogenation<\/title><secondary-title>The Journal of Organic Chemistry<\/secondary-title><\/titles><dates><year>2003<\/year><\/dates><electronic-resource-num>10.1021\/jo034397b<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>4<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Giuseppe Cogoni<\/author><author>Brian de Souza<\/author><author>Denise M. Croker et al.<\/author><\/authors><\/contributors><titles><title>Solubility of (S)-3-(Aminomethyl)-5-Methylhexanoic Acid in Pure and Binary Solvent Mixtures<\/title><secondary-title>Journal of Chemical & Engineering Data<\/secondary-title><\/titles><dates><year>2016<\/year><\/dates><electronic-resource-num>10.1021\/acs.jced.5b00736<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>5<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Borgert BJ<\/author><author>Wallen EM<\/author><author>Pham MN<\/author><\/authors><\/contributors><titles><title>Prostatitis: A Review.<\/title><secondary-title>JAMA<\/secondary-title><\/titles><dates><year>2025<\/year><\/dates><electronic-resource-num>10.1001\/jama.2025.11499<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>6<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Fagan HA<\/author><author>Baldwin DS<\/author><\/authors><\/contributors><titles><title>Pharmacological Treatment of Generalised Anxiety Disorder: Current Practice and Future Directions.<\/title><secondary-title>Expert review of neurotherapeutics<\/secondary-title><\/titles><dates><year>2023<\/year><\/dates><electronic-resource-num>10.1080\/14737175.2023.2211767<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737175.2023.2211767?download=true<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>7<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Strzelczyk A<\/author><author>Schubert-Bast S<\/author><\/authors><\/contributors><titles><title>Psychobehavioural and Cognitive Adverse Events of Anti-Seizure Medications for the Treatment of Developmental and Epileptic Encephalopathies.<\/title><secondary-title>CNS drugs<\/secondary-title><\/titles><dates><year>2022<\/year><\/dates><electronic-resource-num>10.1007\/s40263-022-00955-9<\/electronic-resource-num><urls><related-urls><url>https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-022-00955-9.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>8<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Safarpour Y<\/author><author>Vaziri ND<\/author><author>Jabbari B<\/author><\/authors><\/contributors><titles><title>Restless Legs Syndrome in Chronic Kidney Disease- a Systematic Review.<\/title><secondary-title>Tremor and other hyperkinetic movements (New York, N.Y.)<\/secondary-title><\/titles><dates><year>2023<\/year><\/dates><electronic-resource-num>10.5334\/tohm.752<\/electronic-resource-num><urls><related-urls><url>https:\/\/storage.googleapis.com\/jnl-up-j-tohm-files\/journals\/1\/articles\/752\/6424233a93752.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>9<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Meaadi J<\/author><author>Obara I<\/author><author>Eldabe S et al.<\/author><\/authors><\/contributors><titles><title>The safety and efficacy of gabapentinoids in the management of neuropathic pain: a systematic review with meta-analysis of randomised controlled trials.<\/title><secondary-title>International journal of clinical pharmacy<\/secondary-title><\/titles><dates><year>2023<\/year><\/dates><electronic-resource-num>10.1007\/s11096-022-01528-y<\/electronic-resource-num><urls><related-urls><url>https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-022-01528-y.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>10<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Eva Posp\u00ed\u0161ilov\u00e1<\/author><author>Marek Mihalkovi\u010d<\/author><\/authors><\/contributors><titles><title>Prediction of coherent interfaces between diamond and clathrate structures<\/title><secondary-title>arXiv (2607.00805v1)<\/secondary-title><\/titles><dates><year>2026<\/year><\/dates><electronic-resource-num>10.1016\/j.commatsci.2023.112228<\/electronic-resource-num><urls><related-urls><url>https:\/\/arxiv.org\/abs\/2607.00805v1<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>11<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>J.E. B\u00e4ckvall<\/author><author>S.E. Bystr\u00f6m<\/author><author>Nystr\u00f6m J.E.<\/author><\/authors><\/contributors><titles><title>Stereocontrolled synthesis of (R*R*)- and (R*S*)-5-hydroxy-2-methylhexanoic acid lactones<\/title><secondary-title>Tetrahedron<\/secondary-title><\/titles><dates><year>1985<\/year><\/dates><electronic-resource-num>10.1016\/s0040-4020(01)91414-0<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>12<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><\/authors><\/contributors><titles><title>Pregabalin.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2006<\/year><\/dates><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>13<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Cernea S<\/author><author>Raz I<\/author><\/authors><\/contributors><titles><title>Management of diabetic neuropathy.<\/title><secondary-title>Metabolism: clinical and experimental<\/secondary-title><\/titles><dates><year>2021<\/year><\/dates><electronic-resource-num>10.1016\/j.metabol.2021.154867<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>14<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Tang J<\/author><author>Zhang Y<\/author><author>Liu C et al.<\/author><\/authors><\/contributors><titles><title>Therapeutic Strategies for Postherpetic Neuralgia: Mechanisms, Treatments, and Perspectives.<\/title><secondary-title>Current pain and headache reports<\/secondary-title><\/titles><dates><year>2023<\/year><\/dates><electronic-resource-num>10.1007\/s11916-023-01146-x<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>15<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Park EE<\/author><author>Daniel LL<\/author><author>Dickson AL et al.<\/author><\/authors><\/contributors><titles><title>Initiation of Pregabalin vs Gabapentin and Development of Heart Failure.<\/title><secondary-title>JAMA network open<\/secondary-title><\/titles><dates><year>2025<\/year><\/dates><electronic-resource-num>10.1001\/jamanetworkopen.2025.24451<\/electronic-resource-num><urls><related-urls><url>https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2837132\/park_2025_oi_250698_1753385526.97065.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>16<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>D'Souza RS<\/author><author>Barman R<\/author><author>Joseph A et al.<\/author><\/authors><\/contributors><titles><title>Evidence-Based Treatment of Painful Diabetic Neuropathy: a Systematic Review.<\/title><secondary-title>Current pain and headache reports<\/secondary-title><\/titles><dates><year>2022<\/year><\/dates><electronic-resource-num>10.1007\/s11916-022-01061-7<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>17<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Fu JL<\/author><author>Perloff MD<\/author><\/authors><\/contributors><titles><title>Pharmacotherapy for Spine-Related Pain in Older Adults.<\/title><secondary-title>Drugs & aging<\/secondary-title><\/titles><dates><year>2022<\/year><\/dates><electronic-resource-num>10.1007\/s40266-022-00946-x<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>18<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Swati Shinde<\/author><author>Meena Yadav<\/author><author>Santosh waghmare<\/author><\/authors><\/contributors><titles><title>Quality by Design Based RP-HPLC Method Development and Validation for the Simultaneous Estimation of Pregabalin and Duloxetine in Pure and Pharmaceutical Dosage Form<\/title><secondary-title>International Journal of Drug Delivery Technology<\/secondary-title><\/titles><dates><year>2026<\/year><\/dates><electronic-resource-num>10.25258\/ijddt.16.18s.104<\/electronic-resource-num><urls><related-urls><url>https:\/\/doi.org\/10.25258\/ijddt.16.18s.104<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>19<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Yu-Han Gao<\/author><author>Wen-Xiao Shi<\/author><author>Yuan-Sha Chen et al.<\/author><\/authors><\/contributors><titles><title>Ultrafast Demagnetization Governed by Spin Fluctuations in CaRuO$_{3}$\/SrTiO$_{3}$ Superlattice<\/title><secondary-title>arXiv (2607.02224v1)<\/secondary-title><\/titles><dates><year>2026<\/year><\/dates><urls><related-urls><url>https:\/\/arxiv.org\/abs\/2607.02224v1<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>20<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Sneha Samal<\/author><author>Shrikant Joshi<\/author><author>Stefan Bj\u00f6rklund et al.<\/author><\/authors><\/contributors><titles><title>HVAF Spraying of NiTi Coatings: Microstructure, Phase Transformation and Shape Memory Behavior<\/title><secondary-title>arXiv (2607.01997v1)<\/secondary-title><\/titles><dates><year>2026<\/year><\/dates><urls><related-urls><url>https:\/\/arxiv.org\/abs\/2607.01997v1<\/url><\/related-urls><\/urls><\/record>\n<\/records><\/xml>\n"

"\n\nMolGod<\/database>MOL-GOD<\/source-app>1<\/rec-number>17<\/ref-type>Zdenko Hamer\u0161ak<\/author>Irena Stipeti\u0107<\/author>Amir Avdagi\u0107<\/author><\/authors><\/contributors>An efficient synthesis of (S)-3-aminomethyl-5-methylhexanoic acid (Pregabalin) via quinine-mediated desymmetrization of cyclic anhydride<\/title><secondary-title>Tetrahedron: Asymmetry<\/secondary-title><\/titles><dates><year>2007<\/year><\/dates><electronic-resource-num>10.1016\/j.tetasy.2007.06.014<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>2<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Kaye AD<\/author><author>Armistead G<\/author><author>Amedio LS et al.<\/author><\/authors><\/contributors><titles><title>Evolving Treatment Strategies for Neuropathic Pain: A Narrative Review.<\/title><secondary-title>Medicina (Kaunas, Lithuania)<\/secondary-title><\/titles><dates><year>2025<\/year><\/dates><electronic-resource-num>10.3390\/medicina61061063<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.mdpi.com\/1648-9144\/61\/6\/1063\/pdf?version=1749542630<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>3<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Mark J. Burk<\/author><author>Pieter D. de Koning<\/author><author>Todd M. Grote et al.<\/author><\/authors><\/contributors><titles><title>An Enantioselective Synthesis of (<i>S<\/i>)-(+)-3-Aminomethyl-5-methylhexanoic Acid via Asymmetric Hydrogenation<\/title><secondary-title>The Journal of Organic Chemistry<\/secondary-title><\/titles><dates><year>2003<\/year><\/dates><electronic-resource-num>10.1021\/jo034397b<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>4<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Giuseppe Cogoni<\/author><author>Brian de Souza<\/author><author>Denise M. Croker et al.<\/author><\/authors><\/contributors><titles><title>Solubility of (S)-3-(Aminomethyl)-5-Methylhexanoic Acid in Pure and Binary Solvent Mixtures<\/title><secondary-title>Journal of Chemical & Engineering Data<\/secondary-title><\/titles><dates><year>2016<\/year><\/dates><electronic-resource-num>10.1021\/acs.jced.5b00736<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>5<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Borgert BJ<\/author><author>Wallen EM<\/author><author>Pham MN<\/author><\/authors><\/contributors><titles><title>Prostatitis: A Review.<\/title><secondary-title>JAMA<\/secondary-title><\/titles><dates><year>2025<\/year><\/dates><electronic-resource-num>10.1001\/jama.2025.11499<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>6<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Fagan HA<\/author><author>Baldwin DS<\/author><\/authors><\/contributors><titles><title>Pharmacological Treatment of Generalised Anxiety Disorder: Current Practice and Future Directions.<\/title><secondary-title>Expert review of neurotherapeutics<\/secondary-title><\/titles><dates><year>2023<\/year><\/dates><electronic-resource-num>10.1080\/14737175.2023.2211767<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737175.2023.2211767?download=true<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>7<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Strzelczyk A<\/author><author>Schubert-Bast S<\/author><\/authors><\/contributors><titles><title>Psychobehavioural and Cognitive Adverse Events of Anti-Seizure Medications for the Treatment of Developmental and Epileptic Encephalopathies.<\/title><secondary-title>CNS drugs<\/secondary-title><\/titles><dates><year>2022<\/year><\/dates><electronic-resource-num>10.1007\/s40263-022-00955-9<\/electronic-resource-num><urls><related-urls><url>https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-022-00955-9.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>8<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Safarpour Y<\/author><author>Vaziri ND<\/author><author>Jabbari B<\/author><\/authors><\/contributors><titles><title>Restless Legs Syndrome in Chronic Kidney Disease- a Systematic Review.<\/title><secondary-title>Tremor and other hyperkinetic movements (New York, N.Y.)<\/secondary-title><\/titles><dates><year>2023<\/year><\/dates><electronic-resource-num>10.5334\/tohm.752<\/electronic-resource-num><urls><related-urls><url>https:\/\/storage.googleapis.com\/jnl-up-j-tohm-files\/journals\/1\/articles\/752\/6424233a93752.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>9<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Meaadi J<\/author><author>Obara I<\/author><author>Eldabe S et al.<\/author><\/authors><\/contributors><titles><title>The safety and efficacy of gabapentinoids in the management of neuropathic pain: a systematic review with meta-analysis of randomised controlled trials.<\/title><secondary-title>International journal of clinical pharmacy<\/secondary-title><\/titles><dates><year>2023<\/year><\/dates><electronic-resource-num>10.1007\/s11096-022-01528-y<\/electronic-resource-num><urls><related-urls><url>https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-022-01528-y.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>10<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Eva Posp\u00ed\u0161ilov\u00e1<\/author><author>Marek Mihalkovi\u010d<\/author><\/authors><\/contributors><titles><title>Prediction of coherent interfaces between diamond and clathrate structures<\/title><secondary-title>arXiv (2607.00805v1)<\/secondary-title><\/titles><dates><year>2026<\/year><\/dates><electronic-resource-num>10.1016\/j.commatsci.2023.112228<\/electronic-resource-num><urls><related-urls><url>https:\/\/arxiv.org\/abs\/2607.00805v1<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>11<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>J.E. B\u00e4ckvall<\/author><author>S.E. Bystr\u00f6m<\/author><author>Nystr\u00f6m J.E.<\/author><\/authors><\/contributors><titles><title>Stereocontrolled synthesis of (R*R*)- and (R*S*)-5-hydroxy-2-methylhexanoic acid lactones<\/title><secondary-title>Tetrahedron<\/secondary-title><\/titles><dates><year>1985<\/year><\/dates><electronic-resource-num>10.1016\/s0040-4020(01)91414-0<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>12<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><\/authors><\/contributors><titles><title>Pregabalin.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2006<\/year><\/dates><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>13<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Cernea S<\/author><author>Raz I<\/author><\/authors><\/contributors><titles><title>Management of diabetic neuropathy.<\/title><secondary-title>Metabolism: clinical and experimental<\/secondary-title><\/titles><dates><year>2021<\/year><\/dates><electronic-resource-num>10.1016\/j.metabol.2021.154867<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>14<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Tang J<\/author><author>Zhang Y<\/author><author>Liu C et al.<\/author><\/authors><\/contributors><titles><title>Therapeutic Strategies for Postherpetic Neuralgia: Mechanisms, Treatments, and Perspectives.<\/title><secondary-title>Current pain and headache reports<\/secondary-title><\/titles><dates><year>2023<\/year><\/dates><electronic-resource-num>10.1007\/s11916-023-01146-x<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>15<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Park EE<\/author><author>Daniel LL<\/author><author>Dickson AL et al.<\/author><\/authors><\/contributors><titles><title>Initiation of Pregabalin vs Gabapentin and Development of Heart Failure.<\/title><secondary-title>JAMA network open<\/secondary-title><\/titles><dates><year>2025<\/year><\/dates><electronic-resource-num>10.1001\/jamanetworkopen.2025.24451<\/electronic-resource-num><urls><related-urls><url>https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2837132\/park_2025_oi_250698_1753385526.97065.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>16<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>D'Souza RS<\/author><author>Barman R<\/author><author>Joseph A et al.<\/author><\/authors><\/contributors><titles><title>Evidence-Based Treatment of Painful Diabetic Neuropathy: a Systematic Review.<\/title><secondary-title>Current pain and headache reports<\/secondary-title><\/titles><dates><year>2022<\/year><\/dates><electronic-resource-num>10.1007\/s11916-022-01061-7<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>17<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Fu JL<\/author><author>Perloff MD<\/author><\/authors><\/contributors><titles><title>Pharmacotherapy for Spine-Related Pain in Older Adults.<\/title><secondary-title>Drugs & aging<\/secondary-title><\/titles><dates><year>2022<\/year><\/dates><electronic-resource-num>10.1007\/s40266-022-00946-x<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>18<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Swati Shinde<\/author><author>Meena Yadav<\/author><author>Santosh waghmare<\/author><\/authors><\/contributors><titles><title>Quality by Design Based RP-HPLC Method Development and Validation for the Simultaneous Estimation of Pregabalin and Duloxetine in Pure and Pharmaceutical Dosage Form<\/title><secondary-title>International Journal of Drug Delivery Technology<\/secondary-title><\/titles><dates><year>2026<\/year><\/dates><electronic-resource-num>10.25258\/ijddt.16.18s.104<\/electronic-resource-num><urls><related-urls><url>https:\/\/doi.org\/10.25258\/ijddt.16.18s.104<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>19<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Yu-Han Gao<\/author><author>Wen-Xiao Shi<\/author><author>Yuan-Sha Chen et al.<\/author><\/authors><\/contributors><titles><title>Ultrafast Demagnetization Governed by Spin Fluctuations in CaRuO$_{3}$\/SrTiO$_{3}$ Superlattice<\/title><secondary-title>arXiv (2607.02224v1)<\/secondary-title><\/titles><dates><year>2026<\/year><\/dates><urls><related-urls><url>https:\/\/arxiv.org\/abs\/2607.02224v1<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>20<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Sneha Samal<\/author><author>Shrikant Joshi<\/author><author>Stefan Bj\u00f6rklund et al.<\/author><\/authors><\/contributors><titles><title>HVAF Spraying of NiTi Coatings: Microstructure, Phase Transformation and Shape Memory Behavior<\/title><secondary-title>arXiv (2607.01997v1)<\/secondary-title><\/titles><dates><year>2026<\/year><\/dates><urls><related-urls><url>https:\/\/arxiv.org\/abs\/2607.01997v1<\/url><\/related-urls><\/urls><\/record>\n<\/records><\/xml>\n"